Vincent Enouf

21.9k total citations
79 papers, 2.6k citations indexed

About

Vincent Enouf is a scholar working on Epidemiology, Infectious Diseases and Molecular Biology. According to data from OpenAlex, Vincent Enouf has authored 79 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Epidemiology, 39 papers in Infectious Diseases and 14 papers in Molecular Biology. Recurrent topics in Vincent Enouf's work include Influenza Virus Research Studies (36 papers), Respiratory viral infections research (31 papers) and Viral gastroenteritis research and epidemiology (20 papers). Vincent Enouf is often cited by papers focused on Influenza Virus Research Studies (36 papers), Respiratory viral infections research (31 papers) and Viral gastroenteritis research and epidemiology (20 papers). Vincent Enouf collaborates with scholars based in France, Madagascar and Morocco. Vincent Enouf's co-authors include Sylvie van der Werf, Sylvie Behillil, Jean Cohen, Élisabeth Nicand, Simon Cauchemez, Marie‐Anne Rameix‐Welti, Steven Riley, Neil M. Ferguson, Andrew Rambaut and Maria D. Van Kerkhove and has published in prestigious journals such as The Lancet, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Vincent Enouf

76 papers receiving 2.5k citations

Peers

Countries citing papers authored by Vincent Enouf

Since Specialization

Citations

This map shows the geographic impact of Vincent Enouf's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vincent Enouf with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vincent Enouf more than expected).

Fields of papers citing papers by Vincent Enouf

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vincent Enouf. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vincent Enouf. The network helps show where Vincent Enouf may publish in the future.

Co-authorship network of co-authors of Vincent Enouf

This figure shows the co-authorship network connecting the top 25 collaborators of Vincent Enouf. A scholar is included among the top collaborators of Vincent Enouf based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vincent Enouf. Vincent Enouf is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Community and Hospital‐Based Laboratory Surveillance for Influenza, Respiratory Syncytial Virus, and SARS‐CoV‐2 During the 2023–2024 Season, Lyon, France 2025 ·Journal of Medical Virology ·(unknown), Jean‐Sébastien Casalegno, Benoît Visseaux, (unknown), (unknown), Vincent Enouf, (unknown), (unknown), Marie‐Anne Rameix‐Welti, (unknown), (unknown), Juliette Paireau, Laurence Josset, (unknown), Alexandre Gaymard, Simon Cauchemez, Florence Morfin, Marta C. Nunes, Antonin Bal	0
2	Vaccine effectiveness dynamics against influenza and SARS-CoV-2 in community-tested patients in France 2023–2024 2025 ·Emerging Microbes & Infections ·Claire Nour Abou Chakra, (unknown), (unknown), Vincent Enouf, (unknown), Stéphanie Haïm‐Boukobza, Laurence Josset, Marie‐Anne Rameix‐Welti, Bruno Lina, Marta C. Nunes, (unknown), (unknown)	4
3	Serological responses against seasonal influenza viruses in patients with multiple myeloma treated or untreated with daratumumab after two doses of tetravalent vaccine 2024 ·International Journal of Infectious Diseases ·(unknown), Vincent Enouf, (unknown), Giovanna Melica, François Lemonnier, Jehan Dupuis, Taoufik El Gnaoui, (unknown), Karim Belhadj, Corinne Haïoun, (unknown), Sébastien Gallien, (unknown), Slim Fourati	1
4	Effect of nirsevimab on hospitalisations for respiratory syncytial virus bronchiolitis in France, 2023–24: a modelling study 2024 ·The Lancet Child & Adolescent Health ·(unknown), (unknown), Vincent Enouf, (unknown), (unknown), Juliette Paireau, Marie‐Anne Rameix‐Welti, Michael White, (unknown), (unknown), Isabelle Parent du Châtelet, Jean‐Sébastien Casalegno, Sophie Vaux, Simon Cauchemez	11
5	Emergence and evolution of the Omicron SARS-CoV-2 variant in the island of Martinique 2023 ·Infectious Diseases Now ·(unknown), (unknown), Justine Schaeffer, (unknown), (unknown), Vincent Enouf, (unknown), (unknown), (unknown), (unknown)	0
6	One Health compartment analysis of ESBL-producing Escherichia coli reveals multiple transmission events in a rural area of Madagascar 2023 ·Journal of Antimicrobial Chemotherapy ·(unknown), (unknown), (unknown), (unknown), (unknown), Vincent Enouf, François Roger, Jean‐Marc Collard, Éric Cardinale, Adrien Rieux, Étienne Loire	10
7	Dynamics of SARS-CoV-2 lineages in French Guiana in 2020–2021: 4 epidemic waves with cross-influences from Europe and South America 2022 ·Infection Genetics and Evolution ·(unknown), Anne Lavergne, (unknown), (unknown), (unknown), Antoine Enfissi, Vincent Enouf, Sylvie van der Werf, Denis Blanchet, Magalie Demar, Jean-François Carod, (unknown), Claude Flamand, (unknown), Etienne Simon‐Lorière, Cyril Rousseau, Dominique Rousset	0
8	Prospective evaluation of ID NOW COVID-19 assay used as point-of-care test in an emergency department 2021 ·Journal of Clinical Virology ·(unknown), (unknown), B. Pilmis, (unknown), Gauthier Péan de Ponfilly, (unknown), Vincent Enouf, O. Ganansia, Alban Le Monnier	22
9	A Comprehensive Evaluation of GeneLEAD VIII DNA Platform Combined to Deeplex Myc-TB® Assay to Detect in 8 Days Drug Resistance to 13 Antituberculous Drugs and Transmission of Mycobacterium tuberculosis Complex Directly From Clinical Samples 2021 ·Frontiers in Cellular and Infection Microbiology ·Isabelle Bonnet, Vincent Enouf, F. Morel, (unknown), (unknown), Vincent Jarlier, Alexandra Aubry, J. Robert, Wladimir Sougakoff	20
10	Nasopharyngeal and serological anti SARS-CoV-2 IgG/IgA responses in COVID-19 patients 2021 ·SHILAP Revista de lepidopterología ·Bernadette Crescenzo-Chaigne, Sylvie Behillil, Vincent Enouf, Nicolas Escriou, Stéphane Pêtres, (unknown), Jade Ghosn, Sarah Tubiana, Lila Bouadma, Sylvie van der Werf, Caroline Demeret	7
11	RNA-seq accuracy and reproducibility for the mapping and quantification of influenza defective viral genomes 2020 ·RNA ·Jérémy Boussier, Sandie Munier, (unknown), Bjoern Meyer, Bernadette Crescenzo-Chaigne, Sylvie Behillil, Vincent Enouf, Marco Vignuzzi, Sylvie van der Werf, Nadia Naffakh	16
12	Seasonal Genetic Drift of Human Influenza A Virus Quasispecies Revealed by Deep Sequencing 2018 ·Frontiers in Microbiology ·Cyril Barbezange, Louis Jones, Hervé Blanc, Ofer Isakov, Gershon Celniker, Vincent Enouf, Noam Shomron, Marco Vignuzzi, Sylvie van der Werf	24
13	Striking Similarities in the Presentation and Duration of Illness of Influenza A and B in the Community: A Study Based on Sentinel Surveillance Networks in France and Turkey, 2010-2012 2015 ·PLoS ONE ·Jean Marie Cohen, (unknown), Saverio Caini, Meral A. Cıblak, Anne Mosnier, Isabelle Daviaud, Gonçalo Matias, Selim Badur, Martine Valette, Vincent Enouf, John Paget, Douglas Fleming, (unknown)	24
14	Middle East respiratory syndrome coronavirus: quantification of the extent of the epidemic, surveillance biases, and transmissibility 2013 ·The Lancet Infectious Diseases ·Simon Cauchemez, Christophe Fraser, Maria D. Van Kerkhove, Christl A. Donnelly, Steven Riley, Andrew Rambaut, Vincent Enouf, Sylvie van der Werf, Neil M. Ferguson	248
15	Spatiotemporal Circulation of Influenza Viruses in 5 African Countries During 2008–2009: A Collaborative Study of the Institut Pasteur International Network 2012 ·The Journal of Infectious Diseases ·Jean‐Michel Héraud, Richard Njouom, Dominique Rousset, Hervé Kadjo, Valérie Caro, (unknown), Kathleen Victoir, Jean‐Marc Collard, Arnaud Orelle, (unknown), Euloge Ekaza, Norosoa Harline Razanajatovo, Adamou Lagaré, Leon Biscornet, Vincent Enouf, Sylvie van der Werf, Ousmane M. Diop	25
16	Factors associated with clinical and virological response in patients treated with oseltamivir or zanamivir for influenza A during the 2008–2009 winter 2011 ·Clinical Microbiology and Infection ·Thierry Blanchon, France Mentré, (unknown), (unknown), A. Mosnier, Maude Bouscambert, Fabrice Carrat, Xavier Duval, Vincent Enouf, C. Leport, (unknown)	11
17	Correction: Efficacy of Oseltamivir-Zanamivir Combination Compared to Each Monotherapy for Seasonal Influenza: A Randomized Placebo-Controlled Trial 2010 ·PLoS Medicine ·Xavier Duval, Sylvie van der Werf, Thierry Blanchon, Anne Mosnier, Maude Bouscambert‐Duchamp, Annick Tibi, Vincent Enouf, (unknown), Corine Vincent, Laurent Andréoletti, Florence Tubach, Bruno Lina, France Mentré, Catherine Leport, (unknown)	14
18	Influenza A(H1N1)2009 epidemic in France: virological parameters. 2010 ·Dominique Rousset, Maude Bouscambert‐Duchamp, Vincent Enouf, Martine Valette, (unknown), Valérie Caro, Sylvie van der Werf, Bruno Lina	1
19	Efficacy of Oseltamivir-Zanamivir Combination Compared to Each Monotherapy for Seasonal Influenza: A Randomized Placebo-Controlled Trial 2010 ·PLoS Medicine ·Xavier Duval, Sylvie van der Werf, Thierry Blanchon, Anne Mosnier, Maude Bouscambert‐Duchamp, Annick Tibi, Vincent Enouf, (unknown), Corine Vincent, Laurent Andréoletti, Florence Tubach, Bruno Lina, France Mentré, Catherine Leport, (unknown)	101
20	Bovine rotavirus nonstructural protein 4 produced by Lactococcus lactis is antigenic and immunogenic 2001 ·HAL (Le Centre pour la Communication Scientifique Directe) ·Vincent Enouf, Philippe Langella, (unknown), J. Cohen, Gérard Corthier	5

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact